Selected case studies on client and industry projects

Daewoong Pharmaceutical

Daewoong Pharmaceutical retained Novateur's product development and business development team to support development of two of their immunology assets. The Novateur team ...

Jeon Sengho, CEO, Daewoong Pharmaceutical


Since 2017, IRICoR has engaged Novateur’s team of experts for a number of mandates. Those included Business Development advisory, Competitive ...

Steven J. Klein, PhD, MBA
Vice-President, Business Development, IRICoR

Beyond Air

Beyond’s Air engagement with Novateur Ventures began in 2015 (when Beyond Air was known as AIT Therapeutics). Novateur was engaged ...

Amir Avniel
Co-Founder, COO & President, Beyond Air

Sonic Incytes

Sonic Incytes engaged Novateur’s experienced FDA device regulatory experts to prepare their pre-submission to the FDA as well as accompanying ...

Navigo Proteins GmbH

Navigo Proteins retained Novateur’s expert to evaluate its platform and advise on the best possible Target Product Profiles in the ...

Dr. Henning Afflerbach
Managing Director, Navigo Proteins

adMare BioInnovations

Since 2018 the Novateur expert team has supported adMare in commercializing new technologies in Canada through their extensive industry experience. They ...

Gordon C. McCauley, President and CEO, adMare BioInnovations.

Acerus Pharmaceuticals

Since 2019, the Novateur advisory team has been engaged to support Acerus to improve quality control and supply chain of ...

Edward Gudaitis
President and CEO
Acerus Pharmaceuticals Corporation

Leading North American Venture Capital Fund

A leading North American Venture Fund retained Novateur’s Venture Capital advisory team to draft their prospectus for their upcoming fund. ...

Major US-based Pharmaceutical Company

The Novateur team was engaged in January of 2019 by a major US based pharmaceutical  company with an idea and ...

Major Pharmaceutical Companies

Over the past 5 years, our team has evaluated several over 100 in-licensing opportunities for a number of major pharmaceutical ...

Immune Biosolutions

Immune Biosolutions retained the Novateur Clinical and Business Development team to conduct an assessment of Immune Biosolutions’ therapeutic pipeline and ...

Dr. Frederic Leduc
Co-founder & CEO, Immune Biosolutions

Feldan Therapeutics

Feldan Therapeutics retained Novateur Ventures to conduct a detailed business Model analysis and competitive profile including: A. Competitive market analysis B. Analysis ...

Dr. Francois-Thomas Michaud
CEO, Feldan Therapeutics

The Largest Transactions in the Cannabis Space

Our Cannabis drug development experts have supported the largest marquee transactions in the cannabis space. Our experts advise companies in ...

Canexia Health

Canexia Health engaged Novateur’s expert team in 2020 to run a pan-Canadian reimbursement study as part of Project ACTT -- ...

Michael Ball, CEO, Canexia Health

Innovative Targeting Solutions

Innovative Targeting Solutions retained the Novateur development and commercial team to analyze and vet several of their products candidates in ...

Michael L. Gallo, PhD
President, Innovative Targeting Solutions

Novateur Newsletter

Subscribe to our newsletter for access to latest updates.

Resource Databases

Access Novateur news as well as FDA and Expert Databases.

Relevant Events

Check out conferences and events we are attending!